Skip to content

Efficacy of Intra-articular steroids and Suprascapular nerve block for Diabetic frozen shoulder.

Comparison between ultrasound guided Suprascapular nerve block and the combination of Suprascapular nerve block with Intra-articular steroids via anterior Rotator cuff approach for Adhesive capsulitis, in Diabetes mellitus patients. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077803
Enrollment
70
Registered
2024-12-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M750- Adhesive capsulitis of shoulder Health Condition 2: M750- Adhesive capsulitis of shoulder

Interventions

Intervention1: Suprascapular nerve block: A linear 6-13 MHz US transducer, 22g 9-cm block needle, 5ml of 0.5% of Inj. Bupivacaine + 10µg of Inj. Dexmedetomidine will be used in all subjects. Patients
from lateral to medial and is positioned in the b

Sponsors

Government Medical College and Hospital , Bakshi Nagar , Jammu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adult patients (18-70 years), diagnosed with controlled type 2 Diabetes Mellitus and clinically diagnosed with Frozen shoulder, with a symptom duration of minimum 3 Months, with no radiographic findings on shoulder radiographs except for osteoporosis. 2. Informed written consent 3. Either sex 4. Diagnosed as Frozen shoulder; clinically: pain and restriction in ROM (= 25% loss of ROM in= 2 directions, i.e. abduction, flexion, extension, external rotation, and internal rotation).

Exclusion criteria

Exclusion criteria: 1. Patient refusal 2. Other causes of Frozen Shoulder, such as the Concomitant rotator cuff tear, calcific tendinitis, rheumatic diseases and infection 3. Osteoarthritis, 4. History of high-energy trauma, 5. Previous shoulder surgery, 6. Previous Corticosteroid injection on the affected side within 3 months before the visit of our clinic, 7. Incomplete data before the injection and at 3, 6, 9 and 12 Weeks after the injection, 8. Poor cognitive Function 9. Bleeding diathesis 10.Infection at the site of injection 11.Inability to consent.

Design outcomes

Primary

MeasureTime frame
To evaluate shoulder pain measured by a visual Numeric Pain Rating Scale (NPRS).Timepoint: Baseline(before treatment), after treatment, 3rd week, 6th week, 9th week, 12th week.

Secondary

MeasureTime frame
1. To measure the functional disability evaluated by SPADI and DASH score. 2. Decreased requirement for additional therapies for frozen shoulder 3. To evaluate passive shoulder ROM by goniometerTimepoint: Baseline(before treatment), after treatment, 3rd week, 6th week, 9th week, 12th week.

Countries

India

Contacts

Public ContactDr Jessica Khajuria

Government Medical College and Hospital, Bakshi Nagar, Jammu

drmahajanr@rediffmail.com9419141263

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026